The phrase "real world efficacy" is correct and commonly used in written English.
It is typically used to describe the practical or actual effectiveness of something in real-life situations, rather than just in theory or in a controlled environment. Example: "While the new medication showed promising results in clinical trials, its real world efficacy has yet to be determined in larger, more diverse populations."
Consequently, it will behoove pharma companies to anticipate real world efficacy prior to launch, as the limiting factor for commercialization could soon be not whether a drug is approved by the FDA, based on clinical trial data, but whether it's validated by oncology clinical data companies, based on real-world performance.
Community effectiveness describes how well an intervention will work when it is applied in the community; it may be considered the "real world" efficacy of an intervention.
It would also strongly encourage manufacturers to work with providers and insurers to maximize the real-world efficacy of their products so that reimbursement levels are maintained.
The advantage works both ways, as it allows the sponsors of the clinical trials to reduce costs while simultaneously helping streamline processes and demonstrating real-world efficacy.
Early application and integration of wearable devices and smartphone app data demonstrate compelling benefits around reducing trial costs, streamlining trial processes and demonstrating real-world efficacy.
I then moved within the company to a brand new department called Patient Health, where I designed disease management programs to assess the real-world efficacy of our medications and to improve patient compliance.
The compound, which GSK has developed in collaboration with the U.S. National Institute of Allergy and Infectious Diseases (NIAID), is one of two vaccine candidates that may soon enter real-world efficacy trials; the other was developed by the Public Health Agency of Canada and is produced by NewLink Genetics in Ames, Iowa.
However, when conducting systematic reviews of interventions, studies conducted using low evidentiary designs for evaluating real-world efficacy are generally not appropriate for inclusion [ 47].
A more complete analysis of real-world efficacy and real-world prescribing behavior as well as a broader (societal) analysis may be worthwhile.
Given the urgent need to continue to improve on "real-world" efficacy of antipsychotic treatment [ 20], no construct should be considered sacred and expectations should not be lowered based on limited data.
The fact that only one treatment failure was suspected from our epidemiologic study suggests that laboratory evidence of diminished sensitivity to praziquantel may have negligible effect on real-world efficacy of control programs in this region of China but again, with the caveat that this population had very low-level infection.
